Name | Number of supported studies | Average coverage | |
---|---|---|---|
acinar cell | 3 studies | 86% ± 11% |
Insufficient scRNA-seq data for expression of PNLIP at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 100% | 2104963.73 | 328 / 328 | 69% | 6751.70 | 123 / 178 |
spleen | 73% | 239.23 | 177 / 241 | 0% | 0 | 0 / 0 |
prostate | 57% | 275.73 | 139 / 245 | 14% | 0.45 | 70 / 502 |
liver | 67% | 307.49 | 152 / 226 | 3% | 0.48 | 11 / 406 |
stomach | 62% | 236.89 | 224 / 359 | 6% | 14.46 | 16 / 286 |
adrenal gland | 66% | 187.45 | 170 / 258 | 1% | 0.04 | 2 / 230 |
ovary | 63% | 241.52 | 114 / 180 | 0% | 0.00 | 1 / 430 |
kidney | 56% | 161.54 | 50 / 89 | 1% | 0.06 | 10 / 901 |
uterus | 56% | 156.13 | 96 / 170 | 0% | 0.01 | 2 / 459 |
intestine | 49% | 201.36 | 476 / 966 | 4% | 129.75 | 23 / 527 |
bladder | 52% | 74.10 | 11 / 21 | 1% | 0.05 | 4 / 504 |
esophagus | 52% | 254.08 | 746 / 1445 | 1% | 0.03 | 2 / 183 |
breast | 41% | 596.76 | 186 / 459 | 2% | 0.11 | 23 / 1118 |
lung | 41% | 136.21 | 239 / 578 | 1% | 0.09 | 13 / 1155 |
thymus | 42% | 140.76 | 271 / 653 | 0% | 0.20 | 1 / 605 |
blood vessel | 41% | 304.39 | 542 / 1335 | 0% | 0 | 0 / 0 |
skin | 39% | 209.23 | 700 / 1809 | 1% | 0.07 | 4 / 472 |
adipose | 39% | 772.26 | 472 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 36% | 112.15 | 332 / 929 | 0% | 0 | 0 / 0 |
heart | 36% | 154.17 | 307 / 861 | 0% | 0 | 0 / 0 |
muscle | 32% | 101.64 | 256 / 803 | 0% | 0 | 0 / 0 |
brain | 29% | 92.03 | 756 / 2642 | 1% | 0.02 | 7 / 705 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.11 | 1 / 29 |
eye | 0% | 0 | 0 / 0 | 3% | 0.05 | 2 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006629 | Biological process | lipid metabolic process |
GO_0030299 | Biological process | intestinal cholesterol absorption |
GO_0042572 | Biological process | retinol metabolic process |
GO_0061365 | Biological process | positive regulation of triglyceride lipase activity |
GO_0016042 | Biological process | lipid catabolic process |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0047376 | Molecular function | all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity |
GO_0004806 | Molecular function | triglyceride lipase activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0016298 | Molecular function | lipase activity |
Gene name | PNLIP |
Protein name | Pancreatic triacylglycerol lipase (PL) (PTL) (Pancreatic lipase) (EC 3.1.1.3) |
Synonyms | |
Description | FUNCTION: Plays an important role in fat metabolism. It preferentially splits the esters of long-chain fatty acids at positions 1 and 3, producing mainly 2-monoacylglycerol and free fatty acids, and shows considerably higher activity against insoluble emulsified substrates than against soluble ones. . |
Accessions | P16233 ENST00000369221.2 |